LPL Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,919
Closed -$281K 6280
2026
Q1
$281K Buy
+2,919
New +$292K ﹤0.01% 5228
2021
Q4
Sell
-6,050
Closed -$203K 4400
2021
Q3
$203K Sell
6,050
-1,250
-17% -$42.5K ﹤0.01% 3976
2021
Q2
$215K Buy
+7,300
New +$201K ﹤0.01% 3856
2019
Q3
Sell
-21,585
Closed -$441K 3336
2019
Q2
$441K Sell
21,585
-3,141
-13% -$74K ﹤0.01% 2367
2019
Q1
$695K Buy
+24,726
New +$647K ﹤0.01% 1934

Other funds holding IRMD

LPL Financial's IRMD Position: Q2 2026 in Review

LPL Financial sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 2,919 shares — an estimated $281K sold.

LPL Financial first reported a position in IRMD in Q1 2019 and held it in 5 quarters. The position peaked at $695K in Q1 2019. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • LPL Financial reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • LPL Financial sold 2,919 iRadimed shares in Q2 2026, an estimated $281K.
  • LPL Financial first reported a position in iRadimed in Q1 2019 and held it in 5 quarters.
  • LPL Financial's iRadimed position peaked at $695K in Q1 2019.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.